Changes of resorption and metabolism of cyclosporine after heart transplantation by the influence of gastrointestinal agents

Transplant Proc. 1994 Oct;26(5):2800-1.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Administration, Oral
  • Aluminum Hydroxide / pharmacology
  • Aluminum Hydroxide / therapeutic use
  • Animals
  • Antacids / pharmacology
  • Antacids / therapeutic use
  • Anti-Ulcer Agents / pharmacology*
  • Anti-Ulcer Agents / therapeutic use*
  • Antilymphocyte Serum / therapeutic use
  • Azathioprine / therapeutic use
  • Cimetidine / pharmacology
  • Cimetidine / therapeutic use
  • Cyclosporine / administration & dosage
  • Cyclosporine / metabolism*
  • Cyclosporine / therapeutic use
  • Drug Combinations
  • Famotidine / pharmacology
  • Famotidine / therapeutic use
  • Female
  • Heart Transplantation / immunology
  • Heart Transplantation / physiology*
  • Humans
  • Intestinal Absorption / drug effects*
  • Magnesium Hydroxide / pharmacology
  • Magnesium Hydroxide / therapeutic use
  • Male
  • Middle Aged
  • Omeprazole / pharmacology
  • Omeprazole / therapeutic use
  • Pirenzepine / pharmacology
  • Pirenzepine / therapeutic use
  • Prednisone / therapeutic use
  • Rats
  • Rats, Inbred BN

Substances

  • Antacids
  • Anti-Ulcer Agents
  • Antilymphocyte Serum
  • Drug Combinations
  • aluminum hydroxide, magnesium hydroxide, drug combination
  • Pirenzepine
  • Aluminum Hydroxide
  • Famotidine
  • Cimetidine
  • Cyclosporine
  • Omeprazole
  • Azathioprine
  • Magnesium Hydroxide
  • Prednisone